09:06 AM EDT, 08/15/2024 (MT Newswires) -- Health care stocks were flat to higher premarket Thursday, with the Health Care Select Sector SPDR Fund ( XLV ) up 0.4% and the iShares Biotechnology ETF ( IBB ) recently inactive.

Incyte ( INCY ) and Syndax Pharmaceuticals ( SNDX ) said the US Food and Drug Administration has approved niktimvo to treat chronic graft-versus-host disease. Shares of Syndax Pharmaceuticals ( SNDX ) were up over 3.2% pre-bell.

Bristol-Myers Squibb ( BMY ) made an equity investment in Abata Therapeutics to support the development of the latter's Treg cell therapy products, Abata said. Bristol-Myers Squibb ( BMY ) shares were more than 2% higher premarket.

CureVac ( CVAC ) shares were down 0.3% after it reported a Q2 pre-tax loss of 71.2 million euros ($78.4 million), widening from a loss of 67.4 million euros a year earlier.